Conquer Cancer Recognizes 12 Early-Career Oncologists with Quality Care Symposium Merit Awards

Conquer Cancer Merit Award
Conquer Cancer, the ASCO Foundation, is pleased to announce the recipients of the 2019 Quality Care Symposium Merit Awards. Conquer Cancer Merit Awards recognize oncology fellows’ and trainees’ high-quality research submitted in abstracts to an ASCO-sponsored or cosponsored meeting. Awardees will present their research at the Symposium, taking place Sept. 6-7 in San Diego. Research presented at the ASCO Quality Care Symposium explores the latest strategies and methods for quantification of patient experience, provider efficiency, clinical outcomes, and quality and safety in cancer care. 
 
The following individuals are 2019 Quality Care Symposium Merit Award recipients:
 
Cristiane Decat Bergerot, PhD, MS, BS
City of Hope Comprehensive Cancer Center
 
Kaitlin M. Christopherson, MD
The University of Texas MD Anderson Cancer Center
 
Ryan Huey, MD
The University of Texas MD Anderson Cancer Center
 
Tara L. Kaufmann, MD, MS
Abramson Cancer Center, University of Pennsylvania
 
Ali Raza Khaki, MD
University of Washington
 
Anna Mary Brown Laucis, MD, MPhil
University of Michigan Cancer Center
 
Dan Le, MD, MHA
BC Cancer
 
Sarah Lee, MD
Cleveland Clinic Taussig Cancer Institute
 
Ethan B. Ludmir, MD
The University of Texas MD Anderson Cancer Center
 
Divya Ahuja Parikh, MD
Stanford University School of Medicine
 
Emily Miller Ray, MD, MPH
UNC Lineberger Comprehensive Cancer Center
 
Ana I. Velazquez Manana, MD, MS
UCSF Helen Diller Family Comprehensive Cancer Center
 
The 2019 Conquer Cancer Merits Awards are supported by: 
Anonymous, Agios Pharmaceuticals, Inc., ASCO Employees, Association of Northern California Oncologists, AstraZeneca, Friends and Family of Dr. and Mrs. Ronald Beller, The Berry Family, Dr. and Mrs. Douglas W. Blayney, Breast Cancer Research Foundation®, Bristol-Myers Squibb, Jonathan K. and Cora Y. Cho Charitable Fund, Eisai Inc., Epiphany Partners Inc., Estate of Darla C. Ellis, G1 Therapeutics, GlaxoSmithKline Oncology, Dr. Arti Hurria and Dr. Hyman B. Muss, Ipsen Biopharmaceuticals Inc., Michael Kelley, MD & Elise Hoffman, PharmD, Kidney Cancer Association, Lilly, Loxo Oncology Inc., a wholly owned subsidiary of Eli Lilly and Company, Merck & Co., Inc., Friends and Family of Dr. James B. Nachman, Northern New England Clinical Oncology Society, Dr. Kathleen Pritchard Medicine Professional Corporation, Sarah Cannon Research Institute, Frances A. Shepherd, MD, FASCO, Stephen A. Sherwin, MD, Drs. Rachna and Puneet Shroff, Nizar M. Tannir, MD, TESARO, a GSK Company, and Dr. Michael and Deborah Troner. 
(This listing is current as of August 27, 2019.)